首页> 美国卫生研究院文献>Molecules >Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity
【2h】

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity

机译:具有血管紧张素(1-7)活性的基于MCoTI的环肽的设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report for the first time the design and synthesis of a novel cyclotide able to activate the unique receptor of angiotensin (1-7) (AT1-7), the MAS1 receptor. This was accomplished by grafting an AT1-7 peptide analog onto loop 6 of cyclotide MCoTI-I using isopeptide bonds to preserve the α-amino and C-terminal carboxylate groups of AT1-7, which are required for activity. The resulting cyclotide construct was able to adopt a cyclotide-like conformation and showed similar activity to that of AT1-7. This cyclotide also showed high stability in human serum thereby providing a promising lead compound for the design of a novel type of peptide-based in the treatment of cancer and myocardial infarction.
机译:我们首次报告了能够激活血管紧张素(1-7)(AT1-7)的独特受体MAS1受体的新型环氧化物的设计和合成。这是通过使用异肽键将AT1-7肽类似物接枝到环化物MCoTI-1的环6上来实现的,以保留活性所需的AT1-7的α-氨基和C端羧基。所得的环氧化物构建体能够采用环肽样构象,并显示出与AT1-7相似的活性。该环化物在人血清中也显示出高稳定性,从而为设计新型的基于肽的肽在癌症和心肌梗塞的治疗中提供了有希望的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号